{
  "id": 18330352,
  "title": "Rasonque sales drive up RevMed's stock; whistleblower sues Madrigal over MASH",
  "url": "https://urgent.news/2026/11/05/rasonque-sales-drive-up-revmeds-stock-whistleblower-sues-madrigal",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-05T15:59:19.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/rasonque-sales-drive-up-revmeds-stock-whistleblower-sues-madrigal-over-mash/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Rezera, ANI Pharmaceuticals, Cloudbreak Pharma and Anaheim Bio. RevMed’s stock jumps on early Rasonque sales: The RAS drug developer reported sales of its pancreatic cancer therapy Rasonque for the first time, netting ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}